In subsequent studies, we might utilize organoids as a model to investigate the regulatory mechanisms of MRPL18 in the occurrence and progression of breast cancer, aiming to provide novel insights for personalized medicine. This evidence concerns the gene MRPL18 and breast carcinoma.